Use of Neuroprotective agents for Traumatic Brain Injury [PDF]
, 2019 Traumatic brain injury (TBI) is the leading cause of mortality and morbidity especially in young ages, while over 30 years of neuroprotective agents use for TBI management provided neither any recommended agent for favorable outcome nor less adverse ...
Meshkini, Ali +2 more
core +2 more sources
The value of patient selection in demonstrating treatment effect in stroke recovery trials: Lessons from the CHIMES study of MLC601 (NeuroAiD) [PDF]
, 2015 © 2015 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd. Objective: The CHIMES Study compared MLC601 to placebo in patients with ischemic stroke of intermediate severity in the preceding 72 hours.
Chen, Christopher L H +3 more
core +1 more source
The Effect of Short-Term Treadmill Exercise on the Expression Level of TFAM in the Heart of Nicotine-Sensitized Rats [PDF]
, 2020 Introduction: TFAM (mitochondrial transcription factor A) is involved in mitochondrial biogenesis and induces anti-oxidant and anti-apoptotic effects. Nicotine can also alter the function of cardiovascular system and induce heart failure and other heart ...
Azarbayjani, Mohammad-Ali +3 more
core +2 more sources
NanoART, NeuroAIDS and CNS Drug Delivery [PDF]
Nanomedicine, 2009 A broad range of nanomedicines is being developed to improve drug delivery for CNS disorders. The structure of the blood-brain barrier (BBB), the presence of efflux pumps and the expression of metabolic enzymes pose hurdles for drug-brain entry. Nanoformulations can circumvent the BBB to improve CNS-directed drug delivery by affecting such pumps and ...
Ari, Nowacek, Howard E, Gendelman
openaire +2 more sources
OBSERVING THE OUTCOME OF USING NEUROAID [MLC 601] ON A SAMPLE OF IRAQI STROKE PATIENTS
The Iraqi Journal of Medical Sciences, 2016 Background:Stroke is one of the major causes of morbidity and mortality throughout the world, and carries greater economic costs. [MLC 601] originates from Traditional Chinese Medicine approved in 7 countries as drug that can aids post-stroke recovery ...
Zaki N Hasan +3 more
doaj +4 more sources
Complementary Alternative Medicine: an Education of Guided Self-care in the Elderly Population for Management of Chronic Conditions [PDF]
, 2021 The elderly population, specifically the residents in the Skilled Nursing Facility (SNF) or nursing homes, suffer from chronic conditions, many of which have a psychological and behavioral component.
Gerber, Janice B
core +1 more source
Organizational factors determining access to reperfusion therapies in Ischemic Stroke-Systematic literature review [PDF]
, 2022 Background: After onset of acute ischemic stroke (AIS), there is a limited time window for delivering acute reperfusion therapies (ART) aiming to restore normal brain circulation. Despite its unequivocal benefits, the proportion of AIS patients receiving
Botelho, Ana +4 more
core +2 more sources
The Relationship between Ischemic Stroke Patients with and without Retroflex Tongue: A Retrospective Study [PDF]
, 2017 Background. Patients suffering from stroke exhibit different levels of capability in retroflex tongues, in our clinical observation. This study aims to derive the association of tongue retroflexibility with the degree of severity for stroke patients ...
John Y. Chiang +5 more
core +2 more sources
Neuroaid in Stroke Recovery [PDF]
European Neurology, 2008 condition dictated ( table 2 ). The Neuroaid dose received was 4 tablets, 3 times per day. Treatment was initiated between 1 week and 6 months after stroke, and given to each patient for 2–3 months. Cases presented with neurological impairments affecting motor, balance, speech and visual functions.
openaire +2 more sources
NeuroAiD: Properties for Neuroprotection and Neurorepair [PDF]
Cerebrovascular Diseases, 2013 <b><i>Background:</i></b> Treatments for stroke and other brain injuries are limited. NeuroAiD has been shown to be beneficial in clinical studies. We reviewed the pharmacological effects of NeuroAiD on the normal and ischemic brain and neurons.
C, Heurteaux +8 more
openaire +2 more sources